Purevax RCP FeLV Unia Europejska - polski - EMA (European Medicines Agency)

purevax rcp felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunomodulatorów dla kotów, - koty - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RC Unia Europejska - polski - EMA (European Medicines Agency)

purevax rc

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunomodulatorów dla kotów, - koty - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Felisecto Plus Unia Europejska - polski - EMA (European Medicines Agency)

felisecto plus

zoetis belgium sa - selamectin, sarolaner - produkty przeciwpasożytnicze, insektycydy i repelenty - koty - w przypadku kotów zakażonych mieszanką pasożytów i pcheł, wszy, roztoczy, nicienie żołądkowo-jelitowego lub dżdżownic. ten weterynaryjny produkt leczniczy jest wskazany wyłącznie w przypadku stosowania przeciwko kleszczom i wskazany jest jeden lub więcej innych pasożytów docelowych w tym samym czasie.